TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
MANE

Veradermics, Incorporated

Healthcare · Biotechnology

117.80$ +0.0% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Cash Flow

Veradermics, Incorporated (MANE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -72 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow MANE
Line item 2023 2024 2025
-14 -24 -72
0.2 0.3 1.4
0.9 0.7 -3.9
0.0 0.0 0.0
– – -119
0.0 7.7 0.0
14 60 159
0.4 37 -31
-14 -24 -72

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?